Head And Neck Cancers
An immunotherapy drug is too expensive to be given to NHS patients with head and neck cancers in England, according to the NHS drugs watchdog.
Several new immunotherapy drugs are continuing to show benefits across a range of cancer types, according to data presented at a US conference.
We take a look at our latest immunotherapy clinical trial, testing a new drug for people with head and neck cancers.
Cancer Research UK has launched a new clinical trial to test a drug that could stop a patient’s immune system from protecting tumours.
For hundreds of years the Scottish Highlands have resounded to the names of their famous clans: MacDonald, Campbell, Fraser, and many more. Each clan is a complex,...
A large US study has pinpointed genetic errors that mark out head and neck cancers caused by the human papillomavirus (HPV).
After hearing from Professor Richard Shaw about the beginnings of the HOPON trial and its goals, we now turn to three of the research nurses – Paul Banks, Sarah Dyas and...
One of our highlights from 2014 was the huge success of Stand Up To Cancer.
More than 10 million people tuned in to watch it live on the night and helped us raise...